NewAmsterdam Pharma Co N.V. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Narrden, Netherlands
SEC filing record 1 source field available
Fiscal year end
31 December
NewAmsterdam Pharma Co N.V. has filed 399 SEC EDGAR filings since 04 Aug 2022

SEC filing history

Showing 326-350 of 399 matching filings.

Per page
25
Current page
14
424B3 File 333-268888

424B3

Filing date
25 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-268888

EFFECT filing

Filing date
24 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
24 Apr 2023
Reporting date
24 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-268888

POS AM

Filing date
17 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

FORM 6-K

Filing date
03 Apr 2023
Reporting date
03 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
31 Mar 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-271019

S-8

Filing date
31 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
07 Mar 2023
Reporting date
07 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
03 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
14 Feb 2023
Reporting date
14 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
06 Feb 2023
Reporting date
06 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-268888

424B3

Filing date
31 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-268888

EFFECT filing

Filing date
30 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
17 Jan 2023
Reporting date
17 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-1/A File 333-268888

F-1/A

Filing date
17 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
11 Jan 2023
Reporting date
11 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

FORM 6-K

Filing date
09 Jan 2023
Reporting date
09 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
05 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-1 File 333-268888

F-1

Filing date
20 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
19 Dec 2022
Reporting date
19 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93833

SC 13G

Filing date
02 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-93833

SC 13D

Filing date
02 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .